Gainers
- TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 39.9% to $0.7 during Friday's after-market session. The company's market cap stands at $7.1 million.
- Windtree Therapeutics (NASDAQ:WINT) shares rose 14.86% to $1.7. The company's market cap stands at $1.2 million.
- Aspira Womens Health (NASDAQ:AWH) stock increased by 13.76% to $0.1. The market value of their outstanding shares is at $1.7 million.
- Jin Medical International (NASDAQ:ZJYL) shares moved upwards by 9.42% to $0.72. The market value of their outstanding shares is at $112.7 million.
- Know Labs (AMEX:KNW) shares increased by 8.26% to $1.31. The market value of their outstanding shares is at $3.6 million.
- Cumberland (NASDAQ:CPIX) shares moved upwards by 6.98% to $4.91. The market value of their outstanding shares is at $68.5 million.
Losers
- Impact BioMedical (AMEX:IBO) shares declined by 17.1% to $4.11 during Friday's after-market session. The market value of their outstanding shares is at $47.2 million.
- HeartSciences (NASDAQ:HSCS) stock fell 10.66% to $2.6. The market value of their outstanding shares is at $2.8 million.
- TriSalus Life Sciences (NASDAQ:TLSI) stock fell 9.58% to $5.1. The market value of their outstanding shares is at $155.5 million.
- Plus Therapeutics (NASDAQ:PSTV) stock decreased by 9.34% to $1.07. The market value of their outstanding shares is at $6.3 million.
- TransCode Therapeutics (NASDAQ:RNAZ) stock fell 8.04% to $1.03.
- Wellgistics Health (NASDAQ:WGRX) shares fell 7.87% to $4.57. The company's market cap stands at $237.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
HSCSHeartSciences Inc
$3.352.76%
IBOImpact BioMedical Inc
$0.5804-0.62%
PSTVPlus Therapeutics Inc
$0.6100-3.91%
RNAZTransCode Therapeutics Inc
$13.09-0.38%
TLSITriSalus Life Sciences Inc
$4.90-4.48%
WGRXWellgistics Health Inc
$0.8079100.5%
WINTWindtree Therapeutics Inc
$0.1049-4.64%
ZJYLJin Medical International Ltd
$0.3432-0.46%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
